Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

ClinicalTrials.gov ID: NCT06931405

Public ClinicalTrials.gov record NCT06931405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 3:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study to Evaluate the Safety, Tolerability, and Clinical Activity of BLU-808, a Wild Type KIT Inhibitor, in Chronic Inducible Urticaria and Chronic Spontaneous Urticaria

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a 2-part, proof-of-concept study to be conducted globally, designed to evaluate the safety, tolerability, clinical activity, pharmacokinetics, and pharmacodynamics of BLU-808, a wild type KIT inhibitor, in participants with CIndU (Part A) or CSU (Part B).

Study identification

NCT ID
NCT06931405
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Blueprint Medicines Corporation
Industry
Enrollment
105 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 27, 2025
Primary completion
Dec 30, 2026
Completion
Dec 30, 2026
Last update posted
Jul 21, 2026

2025 – 2026

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
26
Facility City State ZIP Site status
Allervie Clinical Research Birmingham Alabama 35209
Acuro Research, Inc. Little Rock Arkansas 72205
Modena Allergy & Asthma Clinical Research - La Jolla La Jolla California 92037
Allergy & Asthma Associates of Southern California Laguna Niguel California 92677
Allergy & Asthma Medical Group and Research Center San Diego California 92123
Allergy Affiliates Inc. Bradenton Florida 34208
University of South Florida Tampa Florida 33613
Treasure Valley Medical Research Boise Idaho 83706
Endeavor Health Northbrook Illinois 60062
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250
Southern Indiana Clinical Trials New Albany Indiana 47150
The Indiana Clinical Trials Center Plainfield Indiana 46168
Equity Medical - Bowling Green Bowling Green Kentucky 42104
Johns Hopkins University Baltimore Maryland 21224
Institute For Asthma & Allergy Wheaton Maryland 20902
Chesapeake Clinical Research White Marsh Maryland 21236
Henry Ford Health Detroit Michigan 48202
Mayo Clinic Rochester Minnesota 55905
The Clinical Research Center LLC. St Louis Missouri 63141
Montana Medical Research, Inc. Missoula Montana 59808
Equity Medical (at Cameron Dermatology) - New York New York New York 10023
Bernstein Clinical Research Center Cincinnati Ohio 45236
Allergy & Clinical Immunology Associates Pittsburgh Pennsylvania 15241
National Allergy, Asthma & Urticaria Centers of Charleston Charleston South Carolina 29407
Medical University of South Carolina (MUSC) Charleston South Carolina 29425
Reveal Research Institute Dallas Texas 75235
Austin Institute for Clinical Research Pflugerville Texas 78660

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06931405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 21, 2026 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06931405 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →